Skip to main content
SpringerLink
Log in

Inhibition of human neuroblastoma growth by a specific VIP antagonist

  • Original Article
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The 28-amino-acid neuropeptide, vasoactive intestinal peptide (VIP), is a potent mitogen during embryonic development and plays a vital role in brain growth. VIP is also mitogenic for tumor cells, including the human neuroblastoma (NMB). Northern blot analysis has revealed VIP mRNA transcripts in NMB. We now report VIP-like immunoreactivity within these neuroblastoma cells that increased during logarithmic growth and decreased after attaining confluency. About 106 seeded cells secreted 5–40 pg of VIP-like immunoreactivity into the medium. These results suggest an autocrine role for VIP in the regulation of neuroblastoma growth. A VIP hybrid antagonist (neurotensin6–11 VIP7–28) that has been shown to inhibit lung cancer proliferation was now tested for inhibition of neuroblastoma growth. Receptor binding studies indicated that the hybrid antagonist displaced [125I]-VIP binding in the neuroblastoma cells (EC50=5×10−6 M). Furthermore, as measured by thymidine incorporation and by cell counts, the potent VIP hybrid antagonist inhibited neuroblastoma multiplication in a dose-dependent manner. In conclusion, VIP may be an important regulator of growth of nerve cell progenitors and of tumors derived from neuronal origin and intervening with VIP function may lead to improved treatment of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Brenneman D. E., Nicol T., Warren D., and Bowers L. M. (1990) Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglia mitogen.J. Neurosci Res. 25, 386–394.

    Article  PubMed  CAS  Google Scholar 

  • Brodeur G. M., Sekhor G. S., and Goldstein M. N. (1977) Chromosomal aberrations in human neuroblastomas.Cancer 40, 2256–2263.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I. and Brenneman D. E. (1989) VIP molecular biology and neurobiological function.Mol. Neurobiol. 3, 1–36.

    Google Scholar 

  • Gozes I. and Brenneman D. E. (1993) Neuropeptides as growth and differentiation factors in general and VIP in particular.J. Mol. Neurosci. 4, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Shachter P., Shani Y., and Giladi E. (1988) Vasoactive intestinal peptide gene expression from embryos to aging rats.Neuroendocrinology 47, 27–31.

    PubMed  CAS  Google Scholar 

  • Gozes I., Meltzer E., Rubinrout S., Brenneman D. E., and Fridkin M. (1989) Vasoactive intestinal peptide potentiate sexual behavior: inhibition by novel antagonist.Endocrinology 125, 2945–2949.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., McCune S. M., Jacobson L., Warren D., Moody T. W., Fridkin M., and Brenneman D. E. (1991a) An antagonist to vasoactive intestinal peptide: effects on cellular functions in the central nervous system.J. Pharmacol. Exp. Therap. 257, 959–966.

    CAS  Google Scholar 

  • Gozes Y., Brenneman D. E., Fridkin M., Asofsky R., and Gozes I. (1991b) A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.Brain Res. 540, 319–321.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Davidson A., Draui M., and Moody T. W. (1992) The VIP gene is expressed in non-small cell lung cancer cell lines.Biomed. Res. 13(Suppl. 2), 37–39.

    Google Scholar 

  • Gozes I., Reshef A., Salah D., Rubinrout S., and Fridkin M. (1994a) Stearyl-Norleucine-VIP: a novel VIP analogue for noninvasive impotence treatment.Endocrinology 134, 2121–2125.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Brenneman D. E., Lilling G., Davidson A., and Moody T. W. (1994b) Neuropeptide regulation of mitosis.Ann. NY Acad. Sci. 739, 253–261.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Lilling G., Glazer R., Ticher A., Ashkenazi I. C., Davidson A., Rubinraut S., Fridkin M., and Brenneman D. E. (1995) Superactive lipophilic peptides discriminate multiple VIP receptors.J. Pharmacol. Exp. Ther. 273, 161–167.

    PubMed  CAS  Google Scholar 

  • Goosens J. F., Manechez D., Pommery N., Forstecher P., and Henichart J. P. (1993) VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma.Neuropeptides 24, 99–103.

    Article  Google Scholar 

  • Gressens P., Hill J. M., Gozes I., Fridkin M., and Brenneman D. E. (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos.Nature 362, 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Gressens P., Hill J. M., Paindaveine B., Gozes I., Fridkin M., and Brenneman D. E. (1994) Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.J. Clin. Invest. 94, 2020–2027.

    Article  PubMed  CAS  Google Scholar 

  • Harmar T. and Lutz E. (1994) Multiple receptors for PACAP and VIP.TIPS 16, 97–99.

    Google Scholar 

  • Hoshino M., Li M., Zheng L. Q., Suzuki M., Mochizuki T., and Yanaihara N. (1993) Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells.Neurosci. Letts. 159, 35–38.

    Article  CAS  Google Scholar 

  • Maggi M., Baldi E., Finetti G., Franceschelli F., Brocchi A., Lanzillotti R., Serio M., Camboni M. G., and Thiele C. (1994) Identification, characterization, and biological activity of somatostatin receptors on human neuroblastoma cell lines.Cancer Res. 54, 124–133.

    PubMed  CAS  Google Scholar 

  • Moody T. W., Zia F., Draoui M., Brenneman D. E., Fridkin M., Davidson A., and Gozes I. (1993) A novel VIP antagonist inhibits non-small cell lung cancer growth.Proc. Natl. Acad. Sci. USA 90, 4345–4349.

    Article  PubMed  CAS  Google Scholar 

  • Moody T. W., Zia F., Goldstein A. L., Naylor P. H., Sarin E., Brenneman D. E., Koros A. M. C., Reubi J. C., Korman L. Y., Fridkin M., and Gozes I. (1992) VIP analogues inhibit small cell lung cancer growth.Biomed. Res. 13(Suppl. 2), 131–135.

    Google Scholar 

  • O’Dorisio S. M., Fleshmann D. J., Qualman S. J., and O’Dorisio T. M. (1992) Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.Regul. Pept. 37, 213–226.

    Article  PubMed  CAS  Google Scholar 

  • Pence J. C. and Short N. A. (1992) Auto-regulation of neuroblastoma growth by vasoactive intestinal peptide.J. Pediatr. Surg. 27, 935–943.

    Article  PubMed  CAS  Google Scholar 

  • Pincus D. W., DiCicco-Bloom E. M., and Black I. B. (1990) Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts.Nature 343, 564–567.

    Article  PubMed  CAS  Google Scholar 

  • Robberrecht P., Waelbroeck M., Deneef P., Camus J.-C., Vandermeers A., Vandermeers-Pieret M.-C., and Christophe J. (1984) Specific labeling by [125I]helodermin of high affinity VIP receptors in rat liver membranes.FEBS Letts. 172, 55–58.

    Article  Google Scholar 

  • Rosselin G., Anteunis A., Astesano A., Boissard P., Gali P., Hejblum G., and Marie J. C. (1988) Regulation of the vasoactive intestinal peptide receptor.Ann. NY Acad. Sci. 527, 220–237.

    Article  PubMed  CAS  Google Scholar 

  • Schwab M., Alitalo K., Klempnauer K. H., Varmus H. E., Bishop J. M., Gilbert F., Brodeur G., Goldstein M., and Trents J. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.Nature 305, 245–248.

    Article  PubMed  CAS  Google Scholar 

  • Shivers B. D., Gorcs T. J., Gottchall P. E., and Arimura A. (1991) Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions.Endocrinology 129, 69–73.

    Article  Google Scholar 

  • Suda K., Smith D. M., Ghatei M. A., and Bloom S. R. (1992) Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.Neurosci. Letts. 137, 19–23.

    Article  CAS  Google Scholar 

  • Wollman Y., Lilling G., Goldstein M. N., Fridkin M., and Gozes I. (1993) Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells.Brain Res. 624, 339–341.

    Article  PubMed  CAS  Google Scholar 

  • Yu D., Seitz P. K., Selvanayagam P., Rajaraman S., Townsend C. M., and Cooper C. W. (1992) Effects of vasoactive intestinal peptide on adenosine 3′5′-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.Endocrinology 131, 1188–1194.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    G. Lilling & I. Gozes

  2. Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel

    Y. Wollman

  3. Department of Anatomy and Neurobiology, Barnes School of Medicine, Washington University, St. Louis, MO

    M. N. Goldstein

  4. Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel

    S. Rubinraut & M. Fridkin

  5. Section on Developmental and Molecular Pharmacology, Laboratory of Developmental Neurobiology, NICHD, NIH, Bethesda, MD

    D. E. Brenneman

Authors
  1. G. Lilling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Wollman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. N. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Rubinraut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Fridkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. E. Brenneman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Gozes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lilling, G., Wollman, Y., Goldstein, M.N. et al. Inhibition of human neuroblastoma growth by a specific VIP antagonist. J Mol Neurosci 5, 231–239 (1994). https://doi.org/10.1007/BF02736724

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02736724

Index Entries

Search

Navigation